(Q35573056)

English

Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease

scientific article published on December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

8 August 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

author name string

Cazzola M

1

1 reference

Europe PubMed Central

8 August 2017

Di Perna F

2

1 reference

Europe PubMed Central

8 August 2017

Centanni S

3

1 reference

Europe PubMed Central

8 August 2017

Califano C

4

1 reference

Europe PubMed Central

8 August 2017

Donner CF

5

1 reference

Europe PubMed Central

8 August 2017

D'Amato M

6

1 reference

Europe PubMed Central

8 August 2017

D'Amato G

7

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

54

1 reference

Europe PubMed Central

8 August 2017

12

1 reference

Europe PubMed Central

8 August 2017

1083-1086

1 reference

Europe PubMed Central

8 August 2017

Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763760

12 July 2018

The use of bronchodilators in stable chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763760

12 July 2018

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763760

12 July 2018

Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763760

12 July 2018

A dose response study of oxitropium bromide in chronic bronchitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763760

12 July 2018

Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763760

12 July 2018

Oxitropium bromide, a new anticholinergic bronchodilator.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1763760

12 July 2018

Bronchodilatory responses to formoterol, ipratropium, and their combination in patients with stable COPD

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base

1 reference

https://pubmed.ncbi.nlm.nih.gov/10567627

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THX.54.12.1083

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35573056&oldid=1525139381"